Brain-derived neurotrophic factor Val66Met polymorphism is not associated with primary dystonia in a Chinese population

Neurosci Lett. 2013 Jan 15:533:100-3. doi: 10.1016/j.neulet.2012.11.037. Epub 2012 Nov 29.

Abstract

Background: Brain-derived neurotrophic factor (BDNF) is a modulator of synaptic and neural plasticity. Considering the association between dystonia and abnormal sensorimotor cortex plasticity, BDNF may be a candidate gene that confers susceptibility to dystonia. However, the association between Val66Met polymorphism of BDNF gene and primary dystonia is controversial.

Methods: A case-control study was performed to evaluate the association between Val66Met polymorphism in the BDNF gene and primary dystonia in a cohort of 252 Chinese patients and in 214 age- and gender-matched healthy control subjects.

Results: No association was identified between Val66Met polymorphism and primary dystonia or cervical dystonia (P=0.309 and P=0.803 respectively). In a subsequent subgroup analysis, there was also no difference in the distribution for age of onset.

Conclusion: Our findings do not support that BDNF Val66Met polymorphism contributes to the risk of primary dystonia.

MeSH terms

  • Adult
  • Asian People*
  • Brain-Derived Neurotrophic Factor / genetics*
  • Case-Control Studies
  • Dystonic Disorders / ethnology
  • Dystonic Disorders / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Polymorphism, Genetic*
  • Young Adult

Substances

  • Brain-Derived Neurotrophic Factor